The Brinter team is set to attend the NCLifeSci Emerging Company and Technology Forum: Access to Capital, scheduled for March 14, 2024. This forum is a locally driven event in the life sciences industry, providing a platform for emerging companies to discuss and explore various funding mechanisms. The panel at the forum will provide an overview of expectations for 2024 and into 2025, offering valuable insights into the future of the industry. Brinter’s presence at the forum is expected to provide them with a unique opportunity to engage with local industry leaders, potential investors, and peers.
